Remote Monitoring of Cancer Patients With Outpatient Treatment
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Persei Vivarium
- Enrollment
- 34
- Locations
- 1
- Primary Endpoint
- Usability of Caaring® for the management of oncology patients in outpatient oral treatment
- Status
- Completed
- Last Updated
- 11 months ago
Overview
Brief Summary
This project focuses on studying the use of digital platforms for monitoring, between medical visits, parameters such as toxicities and therapeutic adherence.
The goal of this observational study is to know the degree of usability of the Caaring® digital platform in cancer patients undergoing outpatient oral treatment. This will allow in the future to design comparative studies that demonstrate the advantages of using this application in the management of these patients.
Participants will fill out various questionnaires in the Caaring app related to their symptoms, adherence to treatment, quality of life and physical activity, among others.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Cancer patients with adjuvant or metastatic oncological treatment
- •Cancer patients with oral oncological treatment
- •Patients who are able to complete the study questionnaires
- •Patients who are able to handle the application on a smart mobile phone.
- •Informed consent is obtained from the patient.
Exclusion Criteria
- •Patients who will not be able to commit to carrying out the follow-ups or do not have adequate technological skills.
- •Patients with inability to give adequately the informed consent.
Outcomes
Primary Outcomes
Usability of Caaring® for the management of oncology patients in outpatient oral treatment
Time Frame: Day 0 up to 3 months
Percentage of patients with at least 80% of the data completed in the application, Percentage of patients with 100% of the data completed in the application and Percentage of completion per patient
Secondary Outcomes
- Degree of completion of data relating to treatment adherence(Weekly up to 3 months)
- Degree of completion of data related to the toxicity of their treatment(Weekly up to 3 months)
- Quality of the care process through impact on the patient's quality of life: WHOQOL(Day 0 and week 12)
- Quality of the care process through impact on the patient's quality of life: IPAQ(Day 0 and week 12)
- Patient workload(Week 12)